Nucleic acids protect monkeys against the Ebola virus
Nature Medicine
August 23, 2010
Nucleic acid analogs often used to modify gene expression ― called morpholino oligomers ― can protect primates from the lethal effect of the Ebola virus, according an article published this week in Nature Medicine. Though not tested in humans, these findings may highlight a potential for therapies in humans.
No vaccines or therapeutics exist to counter the highly pathogenic Ebola and the related Marburg viruses, which cause viral hemorrhagic fever.
Sina Bavari and her colleagues now show that injection of morpholino oligomers directed against viral genes kept rhesus monkeys from dying after infection with the Ebola or Marburg virus. Importantly, the monkeys were protected even if the morpholinos were administered one hour after exposure to the viruses, highlighting the potential of the approach as a therapeutic strategy in an emergency setting.
doi: 10.1038/nm.2202
Research highlights
-
Aug 12
Ageing: Mutations in the ageing human heart identifiedNature Aging
-
Aug 12
Palaeontology: T. rex and relatives traded big eyes for bigger bitesCommunications Biology
-
Aug 10
Epidemiology: Estimating the risk of SARS-related coronaviruses from bats in Southeast AsiaNature Communications
-
Aug 5
Microbiology: Single switch makes Escherichia coli beneficial insect partnerNature Microbiology
-
Aug 5
Conservation: More than half of unassessable species may be at risk of extinctionCommunications Biology
-
Aug 4
Physiology: Restoring cellular functions in pigs after deathNature